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taphylococcus aureus blood stream infections in Cambodian
dults
. Vlieghe1,∗, T. Phe2, M. Hallin3, O. Denis3, A. Deplano3, B. De
met1, C. Veng2, C. Kham2, L. Lynen1, W. Peetermans4, J. Jacobs1
Institute of Tropical Medicine, Antwerp, Belgium
Sihanouk Hospital Centre of HOPE, Phnom Penh, Cambodia
Hôpital Erasme, Brussels, Belgium
University Hospital Leuven, Louvain, Belgium
Background: Staphylococcus aureus is a common cause of
lood stream infection (BSI); treatment options are jeopardized by
uickly emerging resistance. Epidemiological and resistance data
n invasive S. aureus infections in Cambodia are scarce.
Methods: Isolates and epidemiological data were recovered
rom patients with BSI presenting at Sihanouk Hospital Centre of
OPE between July 2007 and December 2010. Identiﬁcation of S.
ureus isolateswas performed by conventionalmethods. Antibiotic
usceptibilities were assessed using disk diffusion and MicroScan®
Siemens Healthcare) according to CLSI guidelines.Molecular char-
cterization included spa typing, Staphylococcal Chromosomal
assette (SCC) mec typing, Multi Locus Sequence Typing (MLST)
nd screening for presence of PantonValentin Leukocidin (PVL) and
oxic shock syndrome toxin (TSST) encoding genes by PCR.
Results: We observed 51 S.aureus blood stream infections in
6 patients (65.2% male, mean age 42 years (range 16-67 y), rep-
esenting 12.0% of all clinically signiﬁcant blood stream isolates.
omorbidity included diabetes (11.0%) and HIV-infection (23.9%);
.8% of the S. aureus BSI were hospital-associated. In 21(41.2%)
pisodes, skin and soft tissue infections (SSTI) were the presumed
ocus of infection with 8 (38.1%) PVL-associated.
Twelve isolates (23.5%) were methicillin resistant (MRSA);
of those were from HIV+ patients. Resistance rates for
lindamycin, sulfamethoxazole-trimethoprim (SMX-TMP), ﬂuoro-
uinolones and azithromycin were high, especially among MRSA
Table 1). FiveMRSA isolates displayed combined resistance to clin-
amycin, SMX-TMP, tetracyclin, erythromycin and moxiﬂoxacin.
o resistance for vancomycin was noted.
The spa typing revealed 4 different types amongMRSA and 21 in
SSA. Predominant types were t189-ST188 (n=10; 6 were MRSA
CCmec IV), t1379-ST834 (n=4; all MRSA SCCmec IV and TSST-
ositive), t159-ST121 (n=9; 8/9 PVL-positive) and t034-ST1232
n=6; all MSSA and PVL-positive). Five patients had one or more
able 1
ntibiotic resistance in 51 S. aureus from BSI, Cambodia
MRSE (n=12) MSSA (n=39)
Antibiotic n % n %
Penicillin 12 100.0 38 97.4
Clindamycin 12* 100.0 18** 46.2
XMX-TMP 6 50.0 5 12.8
Vancomycin 0 0.0 0 0.0
Moxiﬂoxacin 10 83.3 13 33.3
Azithromycin 11 91.7 27 69.2
* includes 4 isolates with inducible clindamycin resistance.
** includes 8 isolates with inducible clindamycin resistance.fectious Diseases 16S (2012) e317–e473 e437
recurrent BSI episodes; spa typing revealed that 3 were relapses
and 2 reinfections.
Conclusion: S. aureus causing BSI in Cambodia are highly
diverse. MRSA and multi drug resistance are common, especially
in patients with HIV. Treatment options are very limited; the avail-
ability of effective antibiotics in Cambodia is urgently needed. Local
microbiological surveillance data are essential to improve aware-
ness and implement infection control measures.
http://dx.doi.org/10.1016/j.ijid.2012.05.616
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Genotypic characterization of antiviral susceptibility of
Inﬂuenza A viruses isolated in Kenya from 2008 to 2011
M. Wadegu1,∗, W. Bulimo1, R. Achilla1, J. Majanja1, S. Mukunzi1,
F. Osuna2, J. Wangui1, B. Opot1, J. Njiri 1, K. Mitei3, J. Nyambura1,
J. Mwangi1, D. Schnabel1, E. Wurapa1
1 USAMRU-K, Nairobi, Kenya
2 Kenya medical research institute, Nairobi, Kenya
3 USAMRU-Kenya, Nairobi, Kenya
Background: Antivirals play an important role in the treatment
and prevention of severe inﬂuenza infections. The NA inhibitors
(NAI) interfere with the release of progeny inﬂuenza virus from
infected host cells. Mutations in NA protein underpin NAI resis-
tance at the molecular level. H274Y (H275 in N2 numbering)
change in the NA protein alters drug binding activity and results in
Oseltamivir resistance. Here we characterized the antiviral suscep-
tibility of the 2008-2011 inﬂuenzaA strains circulating in Kenya, by
proﬁling knownmolecularmarkers in neuraminidase (NA) protein.
Methods: Nasopharyngeal specimen from outpatients of ages
greater than or equal to two months were screened by PCR (RRT-
PCR) using subtype speciﬁc primers. Positive specimens were
inoculated onto MDCK monolayer. RNA extraction and ampliﬁca-
tion of NA genes was carried out on inﬂuenza positive cultures.
Nucleotide sequencing of the ampliﬁed gene segments was done
and sequences deposited in Gene Bank
Results: In the 2008-2011 inﬂuenza seasons, a total of 108
(13%) isolates were analyzed for susceptibility to NA inhibitors.
In the year 2008, 33 inﬂuenza A/H3N2 and 11 seasonal inﬂuenza
A/H1N1 were included in the study. Inﬂuenza A/H3N2 isolates
had H275 which confers sensitivity to oseltamivir. Majority of the
2008 seasonal inﬂuenza A/H1N1 isolates 64% (7) showed resis-
tant genotype at position 275 of the neuraminidase protein in
which histidine is replaced with tyrosine. 4 (36%) of the seasonal
A/H1N1 isolates, lacked the drug resistant marker depicting sen-
sitivity to the class of drugs. Genetic analysis of the 48 pandemic
inﬂuenza A/H1N1 strains in 2009 showed that all were sensitive to
oseltamivir through possession of histidine at position 274 of the
neuraminidase protein sequence. The same patternwas duplicated
in 2 of the pandemic inﬂuenza A/H1N1 isolates analysed in the year
2010. All the 2011, 14 isolates of inﬂuenza A/H3N2 subtype lacked
the H275Y substitution in the neuraminidase proteinConclusion: In the 2008-2009 and 2009-2010 inﬂuenza sea-
sons three inﬂuenza A virus subtypeswere in circulation: Inﬂuenza
A/H3N2, A/H1N1 and pandemic 2009 A/H1N1. Genotypic data
obtained in this study demonstrate antiviral resistance in seasonal
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crobial activity against S. pneumoniae, S. pyogenes,M. catarrhalis and
H. inﬂuenzae, and remains a useful therapeutic drug for RTI.
http://dx.doi.org/10.1016/j.ijid.2012.05.619438 15th ICID Abstracts / International Journa
nﬂuenza A viruses isolated in Kenya in 2008-2009 despite lack of
idespread antiviral use.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.617
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luoroquinolone resistance via qnrA integron cassette in ESBL
roducing Escherichia coli clinical isolates from Thailand
. Winissorn1,∗, C. Tribuddharat2, P. Naenna1, A. Leelarasamee3,
. Pongpech1
Chulalongkorn University, Bangkok, Thailand
Mahidol University, Bangkok, Thailand
Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
Background: Although qnrA, encoding quinolone resistance
rotein, confers low-level resistance to ﬂuoroquinolone, its role in
uinolone resistance when associated with other resistant mecha-
isms remains unknown.
Methods: One hundred extended-spectrum beta-lactamase
ESBL) producing Escherichia coli were collected from Siriraj Hospi-
al (Bangkok, Thailand) and tested for qnrA by PCR. All qnrA positive
solates were investigated for gyrA mutations and a presence of
lass 1 integron by DNA sequencing and PCR. The locations of qnrA
nd intI1 genes were analyzed by Southern blot hybridization. Phe-
otypic characteristicswere studiedby antimicrobial susceptibility
est and time kill method.
Results: qnrA genes were found in 8% of ESBL-positive E. coli
8/100), conﬁrmed to be qnrA1 by DNA sequencing. All qnrA1 posi-
ive isolates also harbored intI1 gene. Double mutations (S83L and
87N) in gyrA were found in 50% (4/8) of qnrA1 positive isolates.
peciﬁc qnrA1 and intI1 probes showed both qnrA1 and intI1 genes
ould be found on the chromosome and/or plasmids. Some isolates
ossessed two integron elements. The MIC (ciproﬂoxacin) against
he isolate harboring both qnrA1 and gyrA with double mutations
as 2-fold higher than that against the isolate with only gyrA,
nd was much higher than that against the isolate harboring only
nrA1 (MICs of 64 g/ml, 32 g/ml, and 0.12 g/ml, respectively).
ccording to the time kill study, 0.5g/ml of ciproﬂoxacin showed
actericidal activity after six hours of incubation against the isolate
arboring only qnrA1. The bacteriostatic activity against the iso-
ate harboring only gyrA with double mutations could be observed
hen the concentrations of ciproﬂoxacin were ≤256 g/ml. The
egrowth of the isolate carried both genes in 64-128 g/ml at 24
ours of incubationwereobserved.Only 512g/ml of ciproﬂoxacin
howed bactericidal activity after four hours of incubation against
he isolate harboring both qnrA1 and gyrA with double mutations.
Conclusion: qnrA could integrate into the chromosome by class
integrons. Presence of ﬂuoroquinolone resistance elements on
oth plasmid and chromosome indicated high selection pressure
n E. coli and, may be, in other Gram-negative bacteria as well. The
nrAgeneconferredhigher-level ciproﬂoxacin resistanceondouble
utations in gyrA (S83L and D87N) background.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.618fectious Diseases 16S (2012) e317–e473
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Trends in antimicrobial susceptibility among bacterial isolates
from respiratory tract infections in Japanese hospitals partici-
pating in the Levoﬂoxacin Surveillance Group during the period
1994-2010
K. Yamaguchi ∗, A. Ohno, Y. Ishii, F. Kashitani, K. Tadeta
Toho University School of Medicine, Tokyo, Japan
Background: Fluoroquinolones (FQs) are among the most com-
monlyantimicrobialsused to treat respiratory tract infections (RTI).
FQ resistance is still very rare for Streptococcus pneumoniae, Strepto-
coccus pyogenes, Moraxella catarrhalis and Haemophilus inﬂuenzae.
However, FQ resistance in these organisms has been sporadically
reported over the past several years. We have already performed
nationwide surveillance on resistance for FQ and other antimicro-
bials in many bacterial clinical isolates in Japan since 1994. We
report herein surveillance data from 1994 to 2010 for the afore-
mentioned causative pathogens of RTI.
Methods: A total of 14,179 clinical isolates of the 4 species
were collected from 92 centers participating in the Levoﬂoxacin
SurveillanceGroup from1994 to2010 in Japan, andsusceptibility to
17 antibiotics was tested by broth microdilution methods accord-
ing to the Clinical Laboratory Standards Institute (CLSI) guidelines.
Quinolone resistance-determining region (QRDR) mutations in
gyrA, gyrB, parC, or parE were also identiﬁed by direct sequencing
method.
Results: 1. S. pneumoniae: The resistance rate for levoﬂoxacin
has ﬂuctuated at a low level of 1.06±0.71% (geometric mean±SD).
Interestingly, the peak value of MIC distribution in levoﬂoxacin-
susceptible isolates shifted from 0.5 g/mL to 1.0 g/mL from
2004 to 2007. QRDR-mutations were found in some of the LVFX-
susceptible isolates. The susceptibility to macrolides also declined
over time.
2. S. pyogenes: A high level of susceptibility to FQs,
cephalosporins, carbapenems was maintained, but the susceptibil-
ity to macrolides has rapidly decreased since 2002.
3. M. catarrhalis: M. catarrhalis maintained a susceptible rate
of almost 100% for FQs, the advanced-generation cephalosporins,
carbapenems and macrolides.
4. H. inﬂuenzae: Resistant isolates for levoﬂoxacin were not
found or were very few if any. The rate of -lactamase-negative
ampicillin-resistant has rapidly increased from 25.8% in 2002 to
57.9% in 2010.
Conclusion: Levoﬂoxacin stillmaintained ahigh level of antimi-
